FDA Approved: ODEFSEY — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved ODEFSEY, a fixed-dose combination oral antiretroviral therapy. It contains emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide)

Snippet

ORIG AP for ODEFSEY (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE)